Trellu, Marc <br/><br/>
Bioequipotency of idraparinux and idrabiotaparinux after once weekly dosing in healthy volunteers and patients treated for acute deep vein thrombosis.  [electronic resource] 

 -  British journal of clinical pharmacology  May 2013 
 - 1255-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2125 
<br/><br/><label>Standard No.: </label>10.1111/bcp.12009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Anticoagulants--pharmacokinetics<br/>Area Under Curve<br/>Biotin--analogs & derivatives<br/>Factor Xa--metabolism<br/>Factor Xa Inhibitors<br/>Humans<br/>Male<br/>Middle Aged<br/>Oligosaccharides--pharmacokinetics<br/>Therapeutic Equivalency<br/>Venous Thrombosis--drug therapy<br/>Young Adult